SCHEMBL5041213

SCHEMBL5041213

CCOC(=O)C(O)c1c(F)ccc(O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.35
NPC1 O15118 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 3/20 0.31
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
MMP8 P22894 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
MAPT P10636 2/20 0.30
RAB9A P51151 2/20 0.30
KDM4E B2RXH2 2/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041209 0.87 PIN1 (0.34) PIN1NPC1MEN1KMT2ANPSR1
SCHEMBL5043096 0.87 PIN1 (0.34) PIN1NPC1MEN1KMT2ANPSR1
SCHEMBL5043183 0.82 PIN1 (0.36) PIN1NPC1MEN1KMT2ANPSR1
SCHEMBL3255688 0.73 RECQL (0.32) ALDH1A1LMNAHPGDTSHR
SCHEMBL26020487 0.72 RXFP1 (0.39) NPC1MEN1KMT2ANPSR1ALDH1A1
SCHEMBL5045709 0.72 PIN1 (0.35) PIN1NPC1MEN1KMT2ANPSR1
SCHEMBL10757041 0.68 PIN1 (0.45) PIN1NPC1MEN1KMT2AALDH1A1
SCHEMBL10757035 0.68 PIN1 (0.45) PIN1NPC1MEN1KMT2AALDH1A1
SCHEMBL25591718 0.68 PIN1 (0.45) PIN1NPC1MEN1KMT2AALDH1A1
SCHEMBL15850812 0.68 PIN1 (0.42) PIN1NPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PIN1 3824/4885NPC1 3616/4885MEN1 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.